Written and maintained by CASRAI Editorial Board
Last updated
NIHR Biomedical Research Centres (BRCs) are one of the funding categories NIHR itself groups under “infrastructure” rather than “research project” funding — a distinction that matters for how a research administrator should think about them. A BRC is not a grant an individual investigator applies for; it is a sustained, institutional award, held jointly by an NHS trust and a partnering university, that funds the research environment itself rather than a single study. CASRAI’s general NIHR funding guide mentions BRCs in a single sentence alongside other infrastructure awards; this page covers what that categorisation actually means in practice.
What a BRC is
NIHR Biomedical Research Centres bring together academics and clinicians to translate early scientific breakthroughs into potential new treatments, diagnostics, and health technologies. They facilitate early-stage experimental medicine research specifically — the stage between basic discovery science and the kind of proof-of-concept translational work funded through programmes like i4i. NIHR has awarded nearly £800 million in funding to BRC facilities across England, creating a national network built to attract leading scientists, produce world-leading research, and draw further external investment.
Where BRCs are located and how many exist
There are 20 NIHR Biomedical Research Centres, each hosted within an NHS trust and delivered in partnership with a collaborating university. They include centres such as NIHR Barts Biomedical Research Centre, NIHR Birmingham Biomedical Research Centre, NIHR Cambridge Biomedical Research Centre, NIHR Imperial Biomedical Research Centre, NIHR Manchester Biomedical Research Centre, NIHR Oxford Biomedical Research Centre, and the NIHR Biomedical Research Centre at The Royal Marsden and the ICR, among others. A BRC is always named for its host site, not for a single funded project — a structural cue that distinguishes BRC funding from a project grant even before checking the funding mechanism.
What BRCs actually fund and how they operate
BRC funding is sustained rather than project-specific: it supports the environment in which experimental medicine research happens, not one study within it. In practice this means BRCs:
- Provide the critical mass of people and infrastructure focused on biomedical innovation and early translational and experimental medicine research;
- Support capacity building through Early Career Fellowships and training and development opportunities;
- Deliver NIHR-funded research while working alongside other public funders, charities, and the life sciences industry;
- Leverage and attract additional funding from external organisations, extending the reach of the initial NIHR award.
Each BRC is organised around cross-cutting research themes rather than a single disease area — genomics, multimorbidity, data and digital health, imaging, immunology, precision medicine, and rare diseases recur across multiple centres. Some BRCs also host NIHR Translational Research Collaborations, which bring BRC infrastructure together with charity partners to run UK-wide early-phase translational research programmes targeting a specific unmet need.
Why this matters for a research administrator
Because BRC status is held by an institution rather than awarded per project, the practical question for most research administrators is not “how do I apply for BRC funding” but “does my institution host, or partner in, a BRC, and if so, what does that unlock.” A BRC-affiliated site typically has access to specialised infrastructure — from PET scanners and simulation suites to sleep clinics — and to industry-partnering pathways not automatically available to a non-BRC site running the same type of study. Confirming BRC affiliation early, and understanding which research theme a given BRC prioritises, can materially change how a study is resourced and where it is best sited.
Frequently asked questions
Can an individual researcher apply directly for BRC funding?
No. BRC funding is awarded to a partnership between an NHS trust and a university, not to an individual investigator or a single project. Researchers at a BRC-affiliated institution can access BRC-funded infrastructure, capacity, and Early Career Fellowship opportunities, but there is no separate “apply for a BRC” route in the way there is for a project grant.
How is a BRC different from an NIHR Applied Research Collaboration (ARC)?
BRCs fund early-stage experimental medicine and translational research at a specific NHS-university partnership site. ARCs fund applied health and care research addressing local population needs, organised regionally rather than by host site. The two are complementary parts of NIHR’s infrastructure portfolio, not alternative routes to the same funding.
How much funding do BRCs receive in total?
NIHR has awarded nearly £800 million across the 20 BRC facilities in England. Individual centre allocations vary by size and remit and are set through NIHR’s periodic BRC competition rather than published as a single per-centre figure.
